Longevity & AgingPress Release

Losing 1.5 Hours of Sleep Nightly Causes Measurable Weight Gain in At-Risk Adults

A pooled trial analysis finds just 6 weeks of mild sleep restriction adds a pound and increases sedentary time in cardiometabolic-risk adults.

Tuesday, July 7, 2026 1 view
Published in MedPage Today
Article visualization: Losing 1.5 Hours of Sleep Nightly Causes Measurable Weight Gain in At-Risk Adults

Summary

Cutting sleep by just 1.5 hours each night for six weeks led to meaningful weight gain in adults already at elevated cardiometabolic risk, according to a pooled analysis of two randomized trials published in the Annals of Internal Medicine. Participants who reduced their nightly sleep from at least 7 hours gained roughly 1 pound, saw waist circumference grow by half a centimeter, and spent about 17 more minutes per day sedentary compared to those who maintained normal sleep. Researchers from Columbia University note that this rate of weight gain mirrors typical annual weight trends in early and middle adulthood, suggesting chronic mild sleep loss could meaningfully drive obesity and heart disease risk over time. The findings strengthen the case for treating sleep duration as a frontline health conversation.

0:00--:--

Detailed Summary

Sleep is increasingly recognized as a foundational pillar of metabolic health, and new trial data now sharpen exactly how little sleep loss it takes to shift body weight in the wrong direction. For the millions of adults already carrying elevated cardiometabolic risk, even modest, sustained reductions in nightly sleep may quietly accelerate weight gain and sedentary behavior — two drivers of long-term disease.

A pooled analysis of two randomized crossover trials, published in the Annals of Internal Medicine, enrolled 95 adults aged 20 and older who habitually slept at least 7 hours per night. Participants were assigned either to maintain their normal sleep schedule or to delay bedtime by roughly 1.5 hours nightly for 6 weeks, then crossed over to the opposite condition after a washout period. Wrist actigraphy and sleep diaries confirmed adherence, with groups differing by about 78 minutes of actual sleep per night.

After 6 weeks, the sleep-restricted group gained 0.45 kg (approximately 1 lb), with waist circumference increasing by 0.52 cm and whole-body volume rising by 0.56 liters. Sedentary time climbed by 17.2 minutes per day even after controlling for extra time spent in bed. Elevated leptin levels were also detected, hinting at disrupted appetite-regulating hormones as a contributing mechanism.

The researchers, led by Marie-Pierre St-Onge of Columbia University Irving Medical Center, emphasize that a 1.5-hour nightly deficit reflects real-world patterns — 78% of adults sleeping under 7 hours report getting around 6 hours. This is not extreme deprivation; it is Tuesday night. The annualized weight trajectory implied by these findings maps closely onto population-level adult weight creep.

Caveats include the relatively small sample, short trial duration, and the fact that participants already had elevated cardiometabolic risk, limiting generalizability. Nonetheless, the findings strongly support clinicians discussing sleep duration as part of weight management and cardiovascular risk reduction strategies.

Key Findings

  • Losing 1.5 hours of sleep nightly for 6 weeks caused ~1 lb weight gain in cardiometabolic-risk adults.
  • Waist circumference grew 0.52 cm and whole-body volume increased 0.56 L under sleep restriction.
  • Sleep restriction added 17.2 minutes of sedentary time per day, compounding metabolic risk.
  • The rate of weight gain mirrors typical annual adult weight trends, suggesting long-term obesity risk.
  • Elevated leptin levels point to disrupted appetite-hormone signaling as a likely mechanism.

Methodology

This is a news report summarizing a peer-reviewed pooled analysis of two randomized crossover trials published in the Annals of Internal Medicine, a high-credibility journal. The study included 95 adults and used objective actigraphy monitoring, strengthening the evidence base. Crossover design helps control for individual variation, though the sample size remains modest.

Study Limitations

The study included only 95 participants with pre-existing elevated cardiometabolic risk, limiting generalizability to healthy populations. The 6-week observation window cannot confirm whether effects persist, worsen, or reverse over longer periods. The article excerpt is truncated, so mechanistic findings and subgroup analyses may not be fully captured here.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: